Telogen effluvium

Indian Journal of Dermatology, Venereology and Leprology

Volumn 79, Issue 5, 2013, Pages 591-603

  Grover, Chander ^a   Khurana, Ananta ^a  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Acute telogen effluvium; chronic telogen effluvium; iron deficiency anemia; psychosocial stress

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTITHYROID AGENT; ARSENIC; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOTIN; CAFFEINE; CYTOTOXIC AGENT; DEXPANTHENOL; DIMETICONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ETRETIN; ETRETINATE; FERROUS SULFATE; HAIR DYE; IRON; ISOTRETINOIN; LAMOTRIGINE; LITHIUM; MINOXIDIL; NICOTINAMIDE; POLYACRYLIC ACID; PRAMIPEXOLE; SELENIUM; THALLIUM; THYROXINE; VALPROATE MAGNESIUM; WART VIRUS VACCINE;

ACQUIRED ZINC DEFICIENCY; ACRODERMATITIS ENTEROPATHICA; ACTINIC EFFLUVIUM; ACUTE TELOGEN EFFLUVIUM; ALOPECIA AREATA; ANOREXIA NERVOSA; APOPTOSIS; BEREAVEMENT; BIOTIN DEFICIENCY; BLEEDING; CHRONIC KIDNEY FAILURE; CHRONIC STARVATION; CHRONIC TELOGEN EFFLUVIUM; CLINICAL FEATURE; CONFERENCE PAPER; COUNSELING; CRASH DIETING; DERMATOLOGIST; DERMATOMYOSITIS; DIET; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DISORDERS OF CARBOHYDRATE METABOLISM; DRUG WITHDRAWAL; EMOTIONAL STRESS; EPILUMINESCENCE MICROSCOPY; ESSENTIAL FATTY ACID DEFICIENCY; FEVER; HAIR ANALYSIS; HAIR FOLLICLE; HAIR GROWTH; HAIR LOSS; HISTOPATHOLOGY; HODGKIN DISEASE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYPERTHYROIDISM; HYPOPROTEINEMIA; HYPOTHYROIDISM; IDIOPATHIC DISEASE; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; LABORATORY TEST; LIVER DISEASE; MALABSORPTION; MALE TYPE ALOPECIA; MARASMUS; METABOLIC DISORDER; MINOXIDIL WITHDRAWAL; PANCREAS DISEASE; PATHOGENESIS; PHYSIOLOGICAL STRESS; PREGNANCY; PSYCHOGENIC PSEUDOEFFLUVIUM; REASSURANCE; SCALP HAIR; SEASONAL VARIATION; SECONDARY SYPHILIS; SENILITY; SEX DIFFERENCE; SKIN ALLERGY; SKIN BIOPSY; SKIN DISEASE; SOCIAL PSYCHOLOGY; STARVATION; SUBSTITUTION THERAPY; SUNLIGHT; SURGERY; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TELOGEN EFFLUVIUM; THINNING HAIR; ULTRAVIOLET RADIATION; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; ZINC DEFICIENCY;

ACUTE DISEASE; ALOPECIA; ANEMIA, IRON-DEFICIENCY; DIAGNOSIS, DIFFERENTIAL; HUMANS; STRESS, PSYCHOLOGICAL;

EID: 84884377900     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.116731     Document Type: Conference Paper

References (128)

1. Wiedemeyeer K, Schill WB, Loser C. Diseases on hair follicles leading to hair loss part I: Nonscarring alopecias. Kinmed 2004;3:209-14
2. Thiedke CC. Alopecia in women. Am Fam Physician 2003;67:1007-14
3. Gilmore S, Sinclair R. Chronic telogen effluvium is due to a reduction in the variance of anagen duration. Australas J Dermatol 2010;51:163-7
4. Kligman AM. Pathologic dynamics of human hair loss. I. Telogen effuvium. Arch Dermatol 1961;83:175-98
5. Harrison S, Sinclair R. Telogen effluvium. Clin Exp Dermatol 2002;27:389-5
6. Paus R, Olsen EA, Messenger AG. Hair growth disorders. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller As, Leffell DJ, editors. Fitzpatrick's Dermatology in General Medicine. 7th ed. USA; The McGraw-Hill Companies Inc.; 2008. p. 753-77
7. Tosti A, Misciali C, Piraccini BM, Peluso AM, Bardazzi F. Drug induced hair loss and hair growth. Drug Saf 1994;10:310-7
8. Messenger AG, de Berker DA, Sinclair RD. Disorders of Hair. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's textbook of Dermatology. 8th ed. UK: Blackwell Publishing Ltd; 2010. p. 66.27-66
9. de Berker D. Clinical relevance of hair microscopy in alopecia. Clin Exp Dermatol 2002;27:366-72
10. Headington JT. Telogen effluvium. New concepts and review. Arch Dermatol 1993;129:356-63
11. Whiting DA. Chronic telogen effluvium: Increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 1996;35:899-906
12. Sinclair RD, Banfield CC, DDawber RP. Diffuse hair loss. In: Sinclair RD, Banfield CC, Dawber RP editors. Handbook of diseases of the hair and scalp. UK: Blackwell Science Ltd; 1999. p. 64-74
13. Nnoruka EN, Obiagboso I, Maduechesi C. Hair loss in children in South-East Nigeria: Common and uncommon cases. Int J Dermatol 2007;46(Suppl 1):18-22
14. Horenstein VD, Williams LE, Brady AR, Abee CR, Horenstein MG. Age-related diffuse chronic telogen effluvium- type alopecia in female squirrel monkeys (Saimiri boliviensis boliviensis). Comp Med 2005;55:169-74
15. Kligman AM. The human hair cycle. J Invest Dermatol 1959;33:307-16
16. Olsen E. Androgenetic alopecia. In: Disorders of hair growth. New York, NY: McGraw-Hill, Inc; 1994. p. 257-83
17. Shapiro J. Diseases of the hair. In: Raykel R, editor. Conn's current therapy. Philadelphia, Pa: WB Saunders; 1996. p. 739-41
18. Messenger A. Hair loss. Clin Exp Dermatol 2002;27:357
19. Dawber RP, Connor BL. Pregnancy, hair loss, and the pill. Br Med J 1971;4:234
20. Griffiths WA. Diffuse hair loss and oral contraceptives. Br J Dermatol 1973;88:31-6
21. Strumia R. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol 2005;6:165-73
22. Barcaui CB, Gonçalves da Silva AM, Sotto MN, Genser B. Stem cell apoptosis in HIV-1 alopecia. J Cutan Pathol 2006;33:667-71
23. Dawber RPR, Simpson NB, Barth JH. Diffuse alopecia: Endocrine, metabolic and chemical influences on the follicular cycle. In: Dawber RP, editor. Diseases of the Hair and Scalp. Oxford: Blackwell Science; 1997. p. 123-50
24. Hadshiew IM, Foitzik K, Arck PC, Paus R. Burden of hair loss: Stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J Invest Dermatol 2004;123:455-7
25. Goette DK, Odom RB. Alopecia in crash dieters. JAMA 1976;235:2622-3
26. Smith AG. Drug induced disorders of hair and nails. Adverse Drug React Bull 1995;173:655-8
27. Wirth H, Dunsing W, Gloor M. Telogen effluvium following application of selenium disulfide in the guinea pig. Hautarzt 1980;31:502-4
28. Center for Disease Control and Prevention (CDC). Thallium poisoning from eating contaminated cake-Iraq, 2008. MMWR Morb Mortal Wkly Rep 2008;57:1015-8
29. Trüeb RM. Is androgenetic alopecia a photo aggravated dermatosis? Dermatology 2003;207:343-8
30. Braida D, Dubief C, Lang G. Photoageing of hair fiber and photoprotection. Skin Pharmacol 1994;7:73-7
31. Piérard-Franchimont C, Peérard GE. Léffluvium télogène actinique: Une facette de la chronobiologie humaine. Int J Cosmet Sci 1999;21:15-21
32. Tosti A, Piraccini BM, van Neste DJ. Telogen effluvium after allergic contact dermatitis of the scalp. Arch Dermatol 2001;137:187-90
33. de Berker D. Clinical relevance of hair microscopy in alopecia. Clin Exp Dermatol 2002;27:366-72
34. Rook A. Endocrine influences on hair growth. Br Med J 1965;1:609-14
35. Church RE. Hypothyroid hair loss. Br J Dermatol 1956;77:661-3
36. Trost LB, Bergfeld WF, Calogeras E. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 2006;54:824-44
37. Olsen EA. Iron deficiency and hair loss: The jury is still out. J Am Acad Dermatol 2006;54:903-6
38. Williams ML, Packman S, Cowan MJ. Alopecia and periorificial dermatitis in biotin-responsive multiple carboxylase deficiency. J Am Acad Dermatol 1983;9:97-103
39. Chen W, Yang CC, Todorova A, Al Khuzaei S, Chiu HC, Worret WI, et al. Hair loss in elderly women. Eur J Dermatol 2010;20:145-51
40. Bradfield RB, Bailley MA. Hair root response to protein under nutrition. In: Montagna, W, Dobson RC, editors. Advances in Biology of the Skin. Vol. 9. Hair Growth. Oxford: Pergamon Press; 1968. p. 109-11
41. Wells G. Skin disorders in relation to malabsorption. Br Med J 1962;2:937-43
42. Skolnik P, Eaglstein WH, Ziboh VA. Human essential fatty acid deficiency. Arch Dermatol 1977;113:939-41
43. Stimson WH. Vitamin A intoxication in adults; report of a case with a summary of the literature. N Engl J Med 1961;265:369-73
44. Starzel TE, Putman CW, Groth CG, Corman JL, Taubman J. Alopecia ascites and incomplete regeneration after 85-95% liver resection. Am J Surg 1975;129:587-8
45. Scoggins RB, Harlan WR. Cutaneous manifestations of hyperlipidaemia and uraemia. Postgrad Med 1967;41:357-8
46. Klein AW, Rudolf RI, Leydon JJ. Telogen effluvium as a sign of Hodgkin's disease. Arch Dermatol 1973;108:702-3
47. de Berker DA, Messenger AG, Sinclair RD. Disorders of hair. In: Burns DA, Breathnach SM, Cox N, Griffiths CE, editors. Rook's textbook of dermatology. London, England: Blackwell Science; 2004. p. 63.31-6
48. Dawber RP, Simpson NB. Hair and scalp in systemic disease. In: Dawber RP, editor. Diseases of the Hair and Scalp. Oxford: Blackwell Science; 1997. p. 483-527
49. Kennedy C. Syphilis presenting as hair loss. Br Med J 1976;2:854
50. Barcaui CB, Gonçalves da Silva AM, Sotto MN, Genser B. Stem cell apoptosis in HIV-1 alopecia. J Cutan Pathol 2006;33:667-71
51. Gupta AK, Goldfarb MT, Ellis CN, Vorhees JJ. Side-effect profile of acitretin therapy in psoriasis. J Am Acad Dermatol 1989;20:1088-93
52. Bardelli A, Rebora A. Telogen effluvium and minoxidil. J Am Acad Dermatol 1989;21:572-3
53. Bleiker TO, Nicolaou N, Traulsen J, Hutchinson PE. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans. Br J Dermatol 2005;153:103-12
54. Pearce SH. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin Endocrinol (Oxf) 2004;61:589-94
55. Mounsey AL, Reed SW. Diagnosing and treating hair loss. Am Fam Physician 2009; 80:356-62
56. Tuccori M, Pisani C, Bachini L, Pardini M, Mantarro S, Antonioli L, et al. Telogen Effluvium following Bivalent Human Papilloma virus Vaccine Administration: A Report of Two Cases. Dermatology 2012;224:212-4
57. Katz KA, Cotsarelis G, Gupta R, Seykora JT. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease. J Am Acad Dermatol 2006;55(5 Suppl):S103-4
58. Patrizi A, Savoia F, Negosanti F, Posar A, Santucci M, Neri I. Telogen effluvium caused by magnesium valproate and lamotrigine. Acta Derm Venereol 2005;85:77-8
59. Kaimal S, Thappa DM. Diet in dermatology: Revisited. Indian J Dermatol Venereol Leprol 2010;76:103-15
60. Rushton DH. Nutritional factors and hair loss. Clin Exp Dermatol 2002;27:396-404
61. Van Neste MD. Assessment of hair loss: Clinical relevance of hair growth evaluation methods. Clin Exp Dermatol 2002;27:358-65
62. Kullavanijaya P, Gritiyarangsan P, Bisalbutra P, Kulthanan R, Cardin CW. Absence of effects of dimethicone-and non-dimethicone shampoos on daily hair loss rates. J Soc Cosmet Chem 1992;43:195-206
63. Guarrera M, Semino MT, Rebora A. Quantitating hair loss in women: A critical approach. Dermatology 1997;194:12-6
64. Piérard GE, Piérard-Franchimont C, Marks R, Elsner P, for the EEMCO group (European Expert Group on Efficacy Measurement of Cosmetics and Other Topical Products). EEMCO guidance for the assessment of hair shedding and alopecia. Skin Pharmacol Physiol 2004;17:98-110
65. Shapiro J, Wiseman M, Lui H. Practical management of hair loss. Can Fam Physician 2000;46:1469-77
66. Hoffmann R. TrichoScan. Combining epiluminescence microscopy with digital image analysis for the measurement of hair growth in vivo. Eur J Dermatol 2001;11:362-8
67. Rushton DH, De Brouwer B, De Coster W, Van Neste D. Comparative evaluation of scalp hair by phototrichogram and unit area trichogram analysis within the same subjects. Acta Derm Venereol (Stockh) 1993;73:150-3
68. Blume U, Ferracin I, Verschoore M, Czernielewski JM, Schaefer H. Physiology of the vellus hair follicle: Hair growth and sebum excretion. Br J Dermatol 1991;124:21-8
69. Van Neste DJ, Rushton DH. Hair problems in women. Clin Dermatol 1997;15:113-25
70. Sinclair R, Jolley D, Mallari R, Magee J. The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair in loss Women. J Am Acad Dermatol 2004;51:189-99
71. Eudy G, Solomon AR. The histopathology of noncicatricial alopecia. Semin Cutan Med Surg 2006;25:35-40
72. Frieden L, Price V. Androgenetic alopecia. In: Thiers B, Dobson R, editors. Pathogenesis of skin disease. New York: Churchill Livingstone; 1986. p. 41-55
73. Whiting DA. Update on chronic telogen effluvium. Exp Dermatol 1999;8:305-6
74. Miteva M, Tosti A. Dermatoscopy of hair shaft disorders. J Am Acad Dermatol 2013;68:473-81
75. Ross EK, Vincenzi C, Tosti A. Videodermatoscopy in the evaluation of hair and scalp disorders. J Am Acad Dermatol 2006;55:799-806
76. Rakowska A, Slowinska M, Kowalska-Oledzka E, Olszewska M, Rudnicka L. Dermatoscopy in female androgenic alopecia: Method standardization and diagnostic criteria. Int J Trichol 2009;1:123-30
77. Sinclair R. There is no clear association between low serum ferritin and chronic diffuse telogen hair loss. Br J Dermatol 2002;147:982-4
78. Chen W, Yang CC, Todorova A, Al Khuzaei S, Chiu HC, Worret WI, et al. Hair loss in elderly women. Eur J Dermatol 2010;20:145-51
79. Wiedemeyeer K, Schill WB, LOser C. Diseases on hair follicles leading to hair loss part I: Nonscarring alopecias. Skinmed 2004;3:209-14
80. Sinclair R. Diffuse hair loss. Int J Dermatol 1999;38(Suppl 1): 8-18
81. Rushton DH, Ramsey ID, James KC, Norris MJ, Gilkes JJ. Biochemical and trichological characterization of diffuse alopecia in women. Br J Dermatol 1990;123:187-97
82. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) arising in the female sex. Br J Dermatol 1977;97:247-54
83. Whiting DA. Scalp biopsy as a diagnostic and prognostic tool in androgenetic alopecia. Dermatol Ther 1998;8:24-33
84. Whiting DA. Chronic telogen effluvium. Dermatol Clin 1996;14:723-31
85. Sinclair R. Chronic telogen effluvium: A study of 5 patients over 7 years. J Am Acad Dermatol 2005;52:12-6
86. Courtois M, Loussouarn G, Hourseau C, Grollier JF. Aging and hair cycles. Br J Dermatol 1995;132:86-93
87. Baldari M, Guarrera M, Rebora A. Thyroid peroxidase antibodies in patients with telogen effluvium. J Eur Acad Dermatol Venereol 2010;24:980-2
88. Fiedler VC, Gray AC. Diffuse alopecia: Telogen hair loss. In: Olsen EA, editor. Disorders of hair growth: Diagnosis and treatment. 2nd ed. New York: McGraw-Hill; 2003. p. 303-20
89. Schrier SL. Causes and diagnosis of anemia due to iron deficiency. Available from: Http://www.UpToDate.com. [Last accessed on 2005 Apr 18, last updated on 2003 Nov 6]
90. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-23
91. Weismann K. Zinc metabolism and the skin. In: Rook AS, Savin JA, editos. Recent Advances in Dermatology. 5 ed. Inburgh: Churchill Livingstone; 1980. p. 109-29
92. Bradfield RB, Bailley MA. Hair root response to protein undernutrition. In: Montagna W, Dobson RC, editors. Advances in Biology of the Skin. Vol. 9. Hair Growth. Oxford: Pergamon Press; 1968. p. 109-11
93. Hordinsky MK. Medical treatment of noncicatricial alopecia. Semin Cutan Med Surg 2006;25:51-5
94. Brodin MB. Drug-related alopecia. Dermatol Clin 1987;5:571-9
95. Feidler VC Hafeez A. Diffuse alopecia. telogen hair loss. In: Olsen EA, editor. Disorders of Hair growth, diagnosis and treatment. New York: McGraw; 1994. p. 241-55
96. Cash TF. The psychology of hair loss and its implications for patient care. Clin Dermatol 2001;19:161-6
97. Bosse KA, Gieler U. Seelische Faktorenbei Haustkrankheiten: Beitra? gezurpsychosomatischen Dermatologie. Bern: Verlag Hans Huber; 1987
98. Botchkarev VA. Stress and the hair follicle: Exploring the connections. Am J Pathol 2003;162:709-12
99. Paus R. Stress, hair growth control and the neuro-endocrine immune connection. Allergol J 2000;9:611-20
100. Arck PC, Handjiski B, Kuhlmei A, Peters EM, Knackstedt M, Peter A, et al. Mast cell deficient and neurokinin-1 receptor knockout mice are protected from stress-induced hair growth inhibition. J Mol Med (Berl) 2005;83:386-96
101. Peters EM, Arck PC, Paus R. Hair growth inhibition by psychoemotional stress: A mouse model for neural mechanisms in hair growth control. Exp Dermatol 2006;15:1-13
102. Arck PC, Handjiski B, Hagen E, Joachim R, Klapp BF, Paus R. Indications for a''brain-hair follicle axis (BHA)'':Inhibition of keratinocyte proliferation and up-regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P. FASEB J 2001;15:2536-8
103. Arck PC, Handjiski B, Peters EM, Hagen E, Klapp BF, Paus R. Topical minoxidil counteracts stress-induced hair growth inhibition in mice. Exp Dermatol 2003;12:580-90
104. Arck PC, Handjiski B, Peters EM, Peter AS, Hagen E, Fischer A, et al. Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. Am J Pathol 2003;162:803-14
105. Aoki E, Shibasaki T, Kawana S. Intermittent foot shock stress prolongs the telogen stage in the hair cycle of mice. Exp Dermatol 2003;12:371-7
106. Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, Kees F, et al. Human hair follicles display a functional equivalent of the hypothalamic-pituitary- adrenal axis and synthesize cortisol. FASEB J 2005;19:1332-4
107. Peters EM, Handjiski B, Kuhlmei A, Hagen E, Bielas H, Braun A, et al. Neurogenic inflammation in stress induced termination of murine hair growth is promoted by nerve growth factor. Am J Pathol 2004;165:259-71
108. Rupniak NM, Kramer MS. Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol Sci 1999;20:485-90
109. Alvaro G, Di Fabio R. Neurokinin 1 receptor antagonists-current prospects. Curr Opin Drug Discov Devel 2007;10:613-21
110. Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000;80:979-1020
111. McMichael A. Approach to office visits for hair loss in women. Cutis 2011;87:8-9
112. Chartier MB, Hoss DM, Grant-Kels JM. Approach to the adult female patient with diffuse non scarring alopecia. J Am Acad Dermatol 2002;47:809-18;quiz818- 20
113. Kivanç-Altunay I, Savaş C, Gökdemir G, Köşlü A, Ayaydin EB. The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia. Int J Dermatol 2003;42:691-3
114. Baldari M, Montinari M, Guarrera M, Rebora A. Trichodynia is a distinguishing symptom of telogen effluvium J Eur Acad Dermatol Venereol 2009;23:702-38
115. Harth W, Hermes B, Niemeier V, Gieler U. Clinical pictures and classification of somatoform disorders in dermatology. Eur J Dermatol 2006;16:607-14
116. Harth W, Hermes B, Seikowski K, Gieler U. Nihilodermia in psychodermatology. Hautarzt 2007;58:427-34
117. Adamson JW. Iron deficiency and other hypoproliferative anemias. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medicine. 16th ed. New York: McGraw-Hill; 2005. p. 586-92
118. Park J, Song KH, Nam KH. Circumscribed alopecia areata incognita. Australas J Dermatol 2013;54:52-4
119. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 2003;121:985-8
120. Umbreit J. Iron deficiency: A concise review. Am J Hematol 2005;78:225-31
121. Schrier SL. Treatment of anemia due to iron deficiency. Available from: Http://www.UpToDate.com. [Last accessed on 2005 Apr 18, last updated on 2001 Feb 27]
122. Goddard AF, McIntyre AS, Scott BB. Guidelines for the management of iron deficiency anaemia. British Society of Gastroenterology. Gut 2000;46:1-5
123. Bottomley SS. Secondary iron overload disorders. Semin Hematol 1998;35:77-86
124. Esfandiari A, Kelly AP. The effects of tea polyphenolic compounds on hair loss among rodents. J Natl Med Assoc 2005;97:1165-9
125. Tosti A, Comacho-Martinez F, Dawber R. Management of androgenetic alopecia. J Eur Acad Dermatol Venereol 1999;12:205-14
126. Davis MG, Thomas JH, van de Velde S, Boissy Y, Dawson TL Jr, Iveson R, et al. A novel cosmetic approach to treat thinning hair. Br J Dermatol 2011;165(Suppl 3):24-30
127. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999 12;341:491-7
128. Buhl AE. Minoxidil's action in hair follicles. J Invest Dermatol 1989;92:315-20.